Over the past two years, Pfizer has transformed itself into smaller, more agile groups, while retaining the advantages of global reach and scale. In the simplified chart on the right, Pfizer's two main biomedical discovery organizations, Pfizer Global Research & Development and the Biotherapeutics and Bioinnovation Center, deliver promising new molecules to the patient-centric, customer-facing business units within Pfizer's Pharmaceutical segment as well as to its Animal Health segment. These business units then take over further clinical development and life-cycle management. The medicines and vaccines offered by Pfizer are produced under the watchful eye of Pfizer Global Manufacturing.
This organization, with the customer at its center, enables precise focus while capitalizing on Pfizer's unmatched global scale in essential technologies and services.